PDC*line Pharma is - for the first time – an active partner of the Forum BIOTechno Auvergne-Rhône-Alpes 2019. The event will take place June, 11th at the Centre de Congrès du World Trade Center...

Please read our recent publication in the June 2019 edition of Nature Biopharma Dealmakers! The article highlights the key competitive advantages of our technology PDC*vac: a highly potent, versatile...

The PDC*line Pharma management team will be present in full force to 2019 BIO International Convention in Philadelphia from June 3rd to June 6th! ? Contact us through the One-on-One Partnering™ or...

Available now for replay, PDC*line Pharma 's CEO Eric Halioua presentation at the ARM's Meeting Cell & Gene Meeting on the Mediterranean 2019 (Barcelona). Learn more about the unique mechanism of...

PDC*line Pharma CEO Eric Halioua and COO Laurent Levy will be present at the Bio€quity Europe 2019 conference in Barcelona May 20-21! Our CEO will present the company May 21st at 10:30am ? Don’t...

Liège, Belgium, and Grenoble, France, May 7, 2019 - PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today...

Eric Halioua, President & CEO of PDC*line Pharma will make a company presentation at the inaugural Meeting on the Mediterranean in Barcelona (Spain) April 23-25. ? Don’t forget to step by and meet him...

• PDC*line Pharma grants exclusive license in South Korea and exclusive option in other Asian countries to LG Chem Life Sciences Company, for the development and commercialization of PDC*lung cancer...

Eric Halioua, President & CEO of PDC*line Pharma will present the company at the World Immunotherapy Congress USA 2019 taking place March 4th, in the Grand Hyatt, San Diego (USA). ? Don’t forget to...

PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer...